BackBellevue Life Sciences Acquisition - Warrants (09/02/2028) Overview

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for BLACW.

Quarterly EBIT

-$3.67M
↓ 25.67% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

-$22.89M
↓ 255.84% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin